These findings suggest that PRKCQ-AS1 upregulates the expression of MKP1, leading to reduced tamoxifen-induced apoptosis and subsequent tamoxifen resistance in ER + breast cancer cells. This evidence concerns the gene ESR1 and breast carcinoma.